Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

MicroRNA-9 Promotes Immune Cell Activation Through Targeting Negative Regulators of gene expression

EF 2017-18

Résumé
Dendritic cells (DCs) are important cells in the human immune system which are critical for targeting the immune response against specific threats. When a DC senses a threat , it becomes activated which leads the cell to move into the lymph node and direct T-cells against the specific threat. Both DCs and T-cells control whether or not they become activated to be sure they only activate with the right signals. This control is important otherwise these cells could activate by themselves , causing your immune system to attack the body, or to not activate properly causing improper immune responses against bacteria. Our lab is trying to figure out the exact way that DCs and T-cells control their activation, and have found that both of these cell types increase the amount of microRNA-9 when they are activated. MicroRNAs are a way for cells to repress the expression of genes specific for each microRNA, which leads to less of that gene's products in the cell. We believe microRNA-9 repress' the genes of various repressors of activation, and thus more microRNA-9 leads to more activation. If that is the case then perhaps this pathway can be enhanced to increase the activation of these cells or be blocked to stop your immune system from attacking yourself. Overall this research will shed some light on how both DCs and T-cells control their activation and can lead to better understanding of how this can go wrong in autoimmune diseases such as diabetes and rheumatoid arthritis.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
383299
Name
Cordeiro Brendan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
MicroRNA-9 Promotes Immune Cell Activation Through Targeting Negative Regulators of gene expression
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Activation; Autoimmune; Dendritic Cells; Epigenetics; Immunity; Immunology; Microrna; Signalling; T-Cell; Tgf-B
Abstract
Dendritic cells (DCs) are important cells in the human immune system which are critical for targeting the immune response against specific threats. When a DC senses a threat , it becomes activated which leads the cell to move into the lymph node and direct T-cells against the specific threat. Both DCs and T-cells control whether or not they become activated to be sure they only activate with the right signals. This control is important otherwise these cells could activate by themselves , causing your immune system to attack the body, or to not activate properly causing improper immune responses against bacteria. Our lab is trying to figure out the exact way that DCs and T-cells control their activation, and have found that both of these cell types increase the amount of microRNA-9 when they are activated. MicroRNAs are a way for cells to repress the expression of genes specific for each microRNA, which leads to less of that gene's products in the cell. We believe microRNA-9 repress' the genes of various repressors of activation, and thus more microRNA-9 leads to more activation. If that is the case then perhaps this pathway can be enhanced to increase the activation of these cells or be blocked to stop your immune system from attacking yourself. Overall this research will shed some light on how both DCs and T-cells control their activation and can lead to better understanding of how this can go wrong in autoimmune diseases such as diabetes and rheumatoid arthritis.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cordeiro, Brendan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~